ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.07
+0.36 (7.64%)
At close: Nov 20, 2024, 4:00 PM
4.870
-0.200 (-3.94%)
Pre-market: Nov 21, 2024, 7:07 AM EST

ENDRA Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
--10.06-13.18-11.23-11.73-13.31
Upgrade
Depreciation & Amortization
-0.280.230.220.170.12
Upgrade
Other Amortization
----0.232.36
Upgrade
Asset Writedown & Restructuring Costs
-0.0200.01-0.25
Upgrade
Stock-Based Compensation
-11.21.442.11.4
Upgrade
Other Operating Activities
-0.14--0.31--
Upgrade
Change in Inventory
--0.12-1.36-0.69-0.48-0.05
Upgrade
Change in Accounts Payable
--0.820.110.49-0.830.76
Upgrade
Change in Other Net Operating Assets
-0.020.22-1.06-0.21-0.11
Upgrade
Operating Cash Flow
--9.55-12.77-11.12-10.75-8.59
Upgrade
Capital Expenditures
--0.03-0.2-0.05-0.08-0.04
Upgrade
Sale of Property, Plant & Equipment
-0.01----
Upgrade
Investing Cash Flow
--0.02-0.2-0.05-0.08-0.04
Upgrade
Short-Term Debt Issued
-----2.49
Upgrade
Long-Term Debt Issued
----0.34-
Upgrade
Total Debt Issued
----0.342.49
Upgrade
Net Debt Issued (Repaid)
----0.342.49
Upgrade
Issuance of Common Stock
-7.58.413.411.540.13
Upgrade
Other Financing Activities
-0.02----
Upgrade
Financing Cash Flow
-7.528.413.411.888.34
Upgrade
Net Cash Flow
--2.06-4.572.231.05-0.3
Upgrade
Free Cash Flow
--9.58-12.97-11.17-10.82-8.63
Upgrade
Cash Interest Paid
-0.040.060.060-
Upgrade
Levered Free Cash Flow
--5.86-4.78-6.75-6.39-3.57
Upgrade
Unlevered Free Cash Flow
--5.86-4.78-6.75-6.47-4.46
Upgrade
Change in Net Working Capital
-1.720.52-2.211.181.48-0.85
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.